Whitecross et al., Blood 2009
(Lymphoma) :
The apoptotic and therapeutic activities of the histone deacetylase inhibitor ( HDACi ) vorinostat are blocked by overexpression of Bcl-2 or Bcl-X ( L )
Martin et al., Mol Pharmacol 2009
:
BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing
Verheyen et al., Brain 2012
(Neuralgia...) :
Intriguingly, vascular endothelial growth factor or vascular endothelial growth factor receptor inhibitors exerted their effects through a mechanism whereby Hdac6 , through Hsp90, controls vascular endothelial growth factor receptor-2 mediated expression of the anti-apoptotic Bcl2